Status:
RECRUITING
Multicenter Cohort Study of AAV in Hunan of China
Lead Sponsor:
Xiangya Hospital of Central South University
Collaborating Sponsors:
Central South University
The Third Xiangya Hospital of Central South University
Conditions:
ANCA Associated Vasculitis
Eligibility:
All Genders
Brief Summary
This study aimed to explore the incidence of Anti-neutrophil cytoplasmic antibody (ANCA）-associated vasculitis (AAV) progression and its association with adverse consequences. It will enroll approxima...
Detailed Description
The study is a multicenter prospective cohort study, aimed to explore the incidence of AAV and its progression and association with adverse consequences. The study will establish a baseline cohort of ...
Eligibility Criteria
Inclusion
- Fulfill 2012 criteria of ANCA associated vasculitis and agree to sign informed consent
Exclusion
- Do not agree to sign informed consent
Key Trial Info
Start Date :
March 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 16 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05315141
Start Date
March 16 2022
End Date
March 16 2027
Last Update
April 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xiangya hospital
Changsha, Hunan, China, 410008